Eli Lilly and Company (LLY) vs Novartis AG (NVS)
A side-by-side comparison of Eli Lilly and Company and Novartis AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 4, 2026. Differences are shown without an overall score or investment verdict.
LLY
Eli Lilly and Company
$1,142.85HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
NVS
Novartis AG
$141.00HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
Total return — LLY vs NVS
growth of $100 · dividends reinvested · last 10yLLY +1509.0% (+32.0%/yr)NVS +209.1% (+11.9%/yr)LLY compounded faster over this window
Log scale — wide-divergence pair
LLY NVS
LLY vs NVS: by the numbers
- •LLY is the larger company ($1.08T vs $268.00B market cap).
- •NVS trades at the lower trailing earnings multiple (21.27 vs 38.35 P/E), one valuation lens rather than an overall verdict.
- •LLY converts more revenue to profit (33.53% vs 22.93% net margin).
- •LLY grew revenue faster over the past five years (24.42% vs 1.53% CAGR).
- •NVS pays the higher dividend yield (3.36% vs 0.59%).
Metrics side by side
Valuation
| Metric | LLY | NVS |
|---|---|---|
| P/E ratio | 38.35 | 21.27 |
| Forward P/E | 31.23 | 16.01 |
| PEG ratio | 1.33 | 1.38 |
| P/S ratio | 13.51 | 4.82 |
| P/B ratio | 31.77 | 6.45 |
| EV / EBITDA | 26.91 | 13.85 |
| FCF yield | 1.86% | 5.90% |
Profitability
| Metric | LLY | NVS |
|---|---|---|
| Gross margin | 83.40% | 74.44% |
| Operating margin | 49.72% | 30.54% |
| Net margin | 33.53% | 22.93% |
| ROE | 78.84% | 30.71% |
| ROIC | 31.00% | 13.93% |
Dividends
| Metric | LLY | NVS |
|---|---|---|
| Dividend yield | 0.59% | 3.36% |
| Payout ratio | 22.45% | 71.50% |
Growth (annualized)
| Metric | LLY | NVS |
|---|---|---|
| Revenue CAGR (5Y) | 24.42% | 1.53% |
| EPS CAGR (5Y) | 28.96% | 15.42% |
| FCF CAGR (5Y) | 32.91% | 8.92% |
| Total return CAGR (5Y) | 39.08% | 16.94% |
Frequently asked
- Which has the lower trailing P/E, LLY or NVS?
- NVS has the lower trailing P/E: LLY trades at 38.35 and NVS at 21.27. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, LLY or NVS?
- Over the past five years, LLY grew revenue faster — LLY at a 24.42% CAGR versus NVS at 1.53%.
- Does LLY or NVS pay a bigger dividend?
- LLY yields 0.59% and NVS yields 3.36% based on trailing dividends and the latest price.
- Is LLY or NVS more profitable?
- LLY runs the higher net margin — LLY at 33.53% versus NVS at 22.93%.
- How have LLY and NVS total returns compared?
- Over the past 10 years, LLY delivered 32.46% and NVS delivered 11.98% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Eli Lilly P/E ratioNovartis AG P/E ratioEli Lilly dividend yieldNovartis AG dividend yieldEli Lilly ROENovartis AG ROEEli Lilly operating marginNovartis AG operating marginEli Lilly revenue growthNovartis AG revenue growthEli Lilly free cash flowNovartis AG free cash flow
Eli Lilly & Novartis AG appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 4, 2026.